KETARX Ketamine Patch demonstrated extended delivery of ketamine over 40 hours KETARX Ketamine Patch offers flexible dosing through increased size, drug load or concentration of ketamine to better align with intramuscular and intravenous administration Initiating clinical studies by the end of Q4-2022 to support phase 2 and 3 clinical studies in depression, post-traumatic stress disorder…


Previous articleatai Life Sciences to Participate in September Investor Events
Next articleMindMed to Participate in H.C. Wainwright Global Investment ConferenceUSA – EnglishUSA – EnglishUSA – English